Delivery Order SPE2DB20D2014-SPE2DB25FC82A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,293.62 and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract includes no set-aside designation and is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens, with a contract ceiling value of $9,796.98 and an ultimate completion date of August 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens valued at $1,262.15. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a delivery completion date of August 12, 2025. The order represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply relationship with the federal government, with performance taking place at the company's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens valued at $4,911.97 on August 25, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle extending through December 2026. The delivery order is set to be completed...
- The Defense Logistics Agency awarded a delivery order valued at $13,551.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 24, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,956.26 firm fixed-price delivery order on August 15, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC82ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens valued at $6,487.26 on August 22, 2025. This firm fixed price delivery order, which is non-competitive and carries an ultimate completion date of August 25, 2025, represents a pharmaceutical supply requirement fulfilled through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen Drug Corp's substantial pharmaceutical distribution portfolio supporting federal medical procurement, particularly military and veteran healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains the prime Indefinite Delivery Contract valued at $999,999,999.00 through December 2026, which serves as the comprehensive vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. The DLA Troop Support Medical program represents a critical component of federal pharmaceutical logistics, ensuring the availability of essential medications like Trulicity to Defense Health Agency beneficiaries and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 8/22/25 |